Trial · NCT01687413
Results by group1,004
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,004
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Disease-free Survival (DFS) | Radiotherapy | 24 | Participants | ||
| Number of Participants With Disease-free Survival (DFS) | Radiotherapy, Cisplatin | 10 | Participants | ||
| Locoregional Control | Radiotherapy | 26 | Participants | ||
| Locoregional Control | Radiotherapy, Cisplatin | 9 | Participants | ||
| Rate of Distant Metastasis | Radiotherapy | 2 | Participants | ||
| Rate of Distant Metastasis | Radiotherapy, Cisplatin | 0 | Participants | ||
| Disease Specific Survival | Radiotherapy | 24 | Participants | ||
| Disease Specific Survival | Radiotherapy, Cisplatin | 10 | Participants | ||
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | Blood and lymphatic system disorders | 5 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | Blood and lymphatic system disorders | 12 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | Cardiac disorders | 0 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | Cardiac disorders | 1 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | Ear and labyrinth disorders | 11 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | Ear and labyrinth disorders | 4 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | Eye disorders | 2 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | Eye disorders | 0 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | Gastrointestinal disorders | 104 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | Gastrointestinal disorders | 61 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy | General disorders | 38 | number of adverse events | |
| Number of Complications/Acute Toxicity by Organ Class | Radiotherapy, Cisplatin | General disorders | 17 | number of adverse events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01687413/results